secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2025-08-12T23:59:59+00:00
Accession:  0001104659-25-076834
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics changes auditor from Marcum to CBIZ CPAs; no disagreements
------------------------------------------------------------------------------

- Marcum LLP resigned as auditor on August 6, 2025; CBIZ CPAs engaged for FY 2025.
- Marcum's prior reports contained a going concern explanatory paragraph but no adverse opinions.
- No disagreements or reportable events occurred during Marcum's tenure through 2025.
- Change follows CBIZ's acquisition of Marcum's attest business effective November 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465925076834/0001104659-25-076834-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465925076834/tm2421372d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-076834

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer